Analyst Reco. ViewRay, Inc.

Equities

VRAYQ

US92672L1070

Market Closed - OTC Markets Other stock markets 01:27:50 2024-04-18 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	-90.00%		0.00%	0.00%

Apr. 11	North American Morning Briefing : Stock Futures -2-	DJ
Mar. 12	Cowealth Medical China Gets Business Authorization for ViewRay Systems' Products	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing: Treasury Yields Dive as Rate-Rise Fears Ease	23-10-10	DJ
Morgan Stanley Adjusts ViewRay's Price Target to $1 From $2, Keeps Equalweight Rating	23-05-11	MT
B. Riley Downgrades ViewRay to Neutral From Buy, Notes More Cautious, Conservative 2023 Outlook; Trims PT to $1 From $4	23-05-11	MT
Piper Sandler Cuts Price Target on ViewRay to $2 From $6.50, Maintains Overweight Rating	23-04-24	MT
Jefferies Downgrades ViewRay to Hold From Buy, Cuts Price Target to $1.25 From $7	23-04-17	MT
Oppenheimer Downgrades ViewRay to Perform Rating From Outperform	23-04-14	MT
Morgan Stanley Lowers Price Target on ViewRay to $2 From $5.50, Keeps Equalweight Rating	23-04-14	MT
BTIG Downgrades ViewRay to Neutral From Buy	23-04-14	MT
Stifel Downgrades ViewRay to Hold From Buy, Lowers Price Target to $1.75 From $7	23-04-14	MT
B. Riley Lowers ViewRay's Price Target to $4 From $8 After Softer-Than-Expected Q1 Revenue, Keeps Buy Rating	23-04-14	MT
Morgan Stanley Adjusts Price Target on ViewRay to $5.50 From $5, Maintains Equal-Weight Rating	22-11-18	MT
B. Riley Resumes ViewRay With Buy Rating, $8 Price Target	22-11-17	MT
Morgan Stanley Adjusts ViewRay's Price Target to $4.50 from $4, Maintains Equalweight Rating	22-10-11	MT
Piper Sandler Adjusts ViewRay's Price Target to $6 From $7, Reiterates Overweight Rating	22-08-03	MT
BTIG Research Adjusts ViewRay Price Target to $8 From $9	22-06-24	MT
Morgan Stanley Lowers ViewRay's Price Target to $4 From $7, Equalweight Rating Kept	22-05-09	MT
Piper Sandler Adjusts ViewRay's Price Target to $7 From $9, Reiterates Overweight Rating	22-05-06	MT
Stifel Starts ViewRay at Buy With $7 Price Target	22-01-25	MT
B. Riley Upgrades ViewRay to Buy from Neutral, Says Q4 Preannounced Results Roughly In Line with Expectations; Sets $7 PT	22-01-11	MT
VIEWRAY : B. Riley Resumes ViewRay at Neutral with $7 PT, Notes 'Strong' Conviction in Technology, But Remains on Sidelines Amid Pandemic Disruptions	21-10-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. ViewRay, Inc.

Equities

VRAYQ

US92672L1070

Analyst Reco.

Filters